Literature DB >> 19425324

[Introduction to vaccination against cervical cancer].

Hester E de Melker1, Marina A E Conyn-van Spaendonck, Hein J Boot, Roel A Coutinho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19425324

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN： 0028-2162


× No keyword cloud information.
  4 in total

1.  Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.

Authors:  Petra J Woestenberg; Audrey J King; Birgit H B van Benthem; Robine Donken; Suzan Leussink; Fiona R M van der Klis; Hester E de Melker; Marianne A B van der Sande; Christian J P A Hoebe; Johannes A Bogaards
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

2.  Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study.

Authors:  Robine Donken; Adriana Tami; Mirjam J Knol; Karin Lubbers; Marianne A B van der Sande; Hans W Nijman; Toos Daemen; Willibrord C M Weijmar Schultz; Hester E de Melker
Journal:  BMC Public Health       Date:  2018-07-05       Impact factor: 3.295

3.  Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.

Authors:  Petra J Woestenberg; Johannes A Bogaards; Audrey J King; Suzan Leussink; Marianne Ab van der Sande; Christian Jpa Hoebe; Birgit Hb van Benthem
Journal:  Int J Cancer       Date:  2018-12-21       Impact factor: 7.396

4.  Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule.

Authors:  Joske Hoes; Audrey J King; Tessa M Schurink Van't Klooster; Johannes Berkhof; Johannes A Bogaards; Hester E de Melker
Journal:  J Infect Dis       Date:  2022-09-04       Impact factor: 7.759
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.